17
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T0182 | Clopidogrel | (S)-Clopidogrel,SR-25990C | P2Y Receptor |
Clopidogrel (SR-25990C), a P2Y12 receptor antagonist, decreases platelet aggregation. | |||
T0182L | Clopidogrel hydrogen sulfate | (S)-(+)-Clopidogrel hydrogen sulfate,(S)-(+)-Clopidogrel bisulfate,SR-25990C,Clopidogrel | P450 , P2Y Receptor |
Clopidogrel hydrogen sulfate ((S)-(+)-Clopidogrel bisulfate) , a selective, high-affinity P2Y12 receptor antagonist, suppressess fibrinogen binding to platelets and platelet adhesion and aggregation. | |||
T0182L2 | (±) Clopidogrel hydrogen sulfate | Plavix,Clopidogrel hydrogen sulfate,Iscover | P2Y Receptor |
(±) Clopidogrel hydrogen sulfate (Iscover) , an antiplatelet agent pharmacologically and structurally analogous to ticlopidine, is used to inhibit blood clots in various conditions such as cerebrovascular disease, periph... | |||
T38506 | Cis-Clopidogrel-MP derivative | cis-Clopidogrel-MP derivative,Clopidogrel-MP-AM | |
cis-Clopidogrel-MP derivative, also known as Clopidogrel-MP-AM, is a 3’-methoxyacetophenone derivative of Clopidogrel active metabolite. This compound is an orally-active platelet inhibitor specifically targeting the P2Y... | |||
T35431 | (±)-Clopidogrel (hydrochloride) | ||
Clopidogrel is an antithrombic compound whose active metabolite is a selective, irreversible antagonist of the platelet purinergic P2Y12 receptor (IC50 = 100 nM). Clopidogrel inhibits ADP-induced platelet aggregation ex ... | |||
T36222 | 2-oxo Clopidogrel | ||
2-oxo Clopidogrel is an intermediary metabolite of clopidogrel . Clopidogrel is a prodrug that is converted to its active metabolite via two sequential oxidative steps. The first step leads to formation of 2-oxo clopidog... | |||
T5501 | Clopidogrel thiolactone | 2-oxoclopidogrel | P2Y Receptor |
Clopidogrel thiolactone (2-oxoclopidogrel) is a potent P2Y12 receptor inhibitor and a potent antiplatelet aggregation compound.Clopidogrel thiolactone is the active metabolic intermediate resulting from the first oxidati... | |||
T71254 | Clopidogrel HCl | ||
Clopidogrel HCl is the salt form of Clopidogrel (free base), an inhibitor of ADP-induced platelet aggregation acting by direct inhibition of adenosine diphosphate (ADP) binding to its receptor and of the subsequent ADP-m... | |||
T36112 | Clopidogrel Carboxylic Acid (hydrochloride) | ||
Clopidogrel is an antithrombic compound whose active metabolite is a selective, irreversible antagonist of the platelet purinergic P2Y12 receptor (IC50 = 100 nM). Clopidogrel inhibits ADP-induced platelet aggregation ex ... | |||
T126236 | Clopidogrel Related Compound C | ||
Clopidogrel Related Compound C is a useful organic compound for research related to life sciences. The catalog number is T126236 and the CAS number is 120202-71-3. | |||
T125846 | Clopidogrel Related Compound B | ||
Clopidogrel Related Compound B is a useful organic compound for research related to life sciences. The catalog number is T125846 and the CAS number is 144750-52-7. | |||
T125853 | Clopidogrel Related Compound A | ||
Clopidogrel Related Compound A is a useful organic compound for research related to life sciences. The catalog number is T125853 and the CAS number is 144457-28-3. | |||
T0179 | Ticagrelor | AR-C 126532XX,AZD6140 | P450 , P2Y Receptor |
Ticagrelor (AR-C 126532XX), produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European U... | |||
T21059 | Ticagrelor metabolite M5 | Ticagrelor metabolite M5,,T437700,AR-C133913XX | P2Y Receptor |
Ticagrelor metabolite M5 (T437700) is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor. Compared to Clopidogrel, Ticagrelor has faster and more consistent inhibition on ADP-receptors. Ti... | |||
T20765 | Atorvastatin | HMG-CoA Reductase , Autophagy | |
Atorvastatin is an orally active HMG-CoA reductase inhibitor that has the ability to effectively lower blood lipids by activating liver cytochrome p450 to accelerate metabolism. Atorvastatin inhibited proliferation and i... | |||
T71363 | ACT-281959 | ||
ACT-281959, a prodrug of ACT-246475, is a novel potent and selective P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel. ACT-281959 showed antithrombotic efficacy after oral administr... | |||
T75242 | Bivalirudin TFA | ||
Bivalirudin TFA, a synthetic 20-residue peptide, serves as a reversible inhibitor of thrombin. Its IC50 value highlights its target specificity in vitro, where, combined with Eptifibatide (8 mg/mL) at a low concentration... |